--- title: "Biosig Technologies (NASDAQ:BSGM) Releases Earnings Results, Misses Estimates By $0.70 EPS" type: "News" locale: "en" url: "https://longbridge.com/en/news/253380895.md" description: "Biosig Technologies (NASDAQ:BSGM) reported earnings of ($0.74) per share, missing estimates by $0.70. The stock traded down to $4.97 with 865,064 shares exchanged. Institutional investors have increased their positions, with Geode Capital Management raising its holdings by 73.2%. Analyst Ascendiant Capital Markets upgraded the price target from $2.50 to $10.00, maintaining a \"buy\" rating. Despite the earnings miss, the company continues to develop advanced medical devices for treating cardiovascular arrhythmias." datetime: "2025-08-18T02:25:51.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/253380895.md) - [en](https://longbridge.com/en/news/253380895.md) - [zh-HK](https://longbridge.com/zh-HK/news/253380895.md) generator: "portal-rs" --- # Biosig Technologies (NASDAQ:BSGM) Releases Earnings Results, Misses Estimates By $0.70 EPS Biosig Technologies (NASDAQ:BSGM - Get Free Report) posted its quarterly earnings results on Friday. The company reported ($0.74) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.70), Zacks reports. Get **Biosig Technologies** alerts: ## Biosig Technologies Stock Performance NASDAQ:BSGM traded down $0.13 on Friday, hitting $4.97. 865,064 shares of the stock were exchanged, compared to its average volume of 914,598. Biosig Technologies has a 52 week low of $0.23 and a 52 week high of $14.11. The company's 50-day moving average price is $6.12 and its 200 day moving average price is $3.17. ## Institutional Trading of Biosig Technologies A number of hedge funds and other institutional investors have recently made changes to their positions in BSGM. Geode Capital Management LLC lifted its holdings in shares of Biosig Technologies by 73.2% during the second quarter. Geode Capital Management LLC now owns 221,164 shares of the company's stock worth $1,580,000 after buying an additional 93,493 shares in the last quarter. Jane Street Group LLC acquired a new position in shares of Biosig Technologies in the second quarter valued at approximately $501,000. Finally, Bank of America Corp DE increased its position in Biosig Technologies by 2,601.2% during the 2nd quarter. Bank of America Corp DE now owns 8,671 shares of the company's stock valued at $62,000 after purchasing an additional 8,350 shares during the period. 7.16% of the stock is currently owned by institutional investors and hedge funds. ## Analyst Upgrades and Downgrades Separately, Ascendiant Capital Markets lifted their price objective on shares of Biosig Technologies from $2.50 to $10.00 and gave the stock a "buy" rating in a research note on Friday, June 6th. **View Our Latest Report on BSGM** ## About Biosig Technologies (Get Free Report) BioSig Technologies, Inc, together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. ## Featured Articles - Five stocks we like better than Biosig Technologies - Transportation Stocks Investing - 3 Restaurant Stocks That Will Outperform in Q3 and Q4 - Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours? - The Midstream Energy Play That Keeps Powering Higher - What Are the FAANG Stocks and Are They Good Investments? - Ethereum Near All-Time High: 3 Stocks Stacking ETH in Treasuries *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.* ## Should You Invest $1,000 in Biosig Technologies Right Now? Before you consider Biosig Technologies, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Biosig Technologies wasn't on the list. While Biosig Technologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [BSGM.US](https://longbridge.com/en/quote/BSGM.US.md) - [STEX.US](https://longbridge.com/en/quote/STEX.US.md) ## Related News & Research - [STEX: First revenue from tokenized gold, $41.8M liquidity, and new product launches drive growth](https://longbridge.com/en/news/295977814.md) - [Streamex adds Inspira Financial as custodian for GLDY Class B shares](https://longbridge.com/en/news/293334676.md) - [Streamex teams with Wintermute to provide 24/7 instant liquidity for GLDY token](https://longbridge.com/en/news/293603089.md) - [Streamex launches share buyback of up to 10 million shares at up to $2 each](https://longbridge.com/en/news/291925209.md) - [Biosig Technologies (NASDAQ:STEX) CIO Mitchell Young Williams Sells 263,863 Shares](https://longbridge.com/en/news/285132932.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**